CPRX

Q: What is the price of Catalyst Pharmaceuticals (CPRX) today?

A cotação de Catalyst Pharmaceuticals (CPRX) hoje está em $ 31.18, com uma variação de The stock began the year trading around $ 23.34 and is currently priced at $ 31.18. negociando na casa dos $ 23.34 e hoje está em $ 31.18. Acompanhe o and track broader market trends directly on the platform.

Q: When does Catalyst Pharmaceuticals (CPRX) pay dividends?

Catalyst Pharmaceuticals (CPRX) did not pay dividends over the past year.

Q: Is Catalyst Pharmaceuticals (CPRX) a good investment?

Atualmente, Catalyst Pharmaceuticals (CPRX) está cotada a $ 31.18, com um P/L de 17.88, This represents a 2,086% premium compared to its historical average P/E. uma variação de 31.12 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 31.12%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Catalyst Pharmaceuticals Inc.

Price

$ 31.18

return (12m)

31.12%

p/e

17.88

p/bv

4.02

DIVIDEND YIELD

0.00%

CPRX price

CPRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

20.62%

3 months

28.15%

1 year

31.12%

2 years

87.15%

5 years

467.94%

10 years

5,229.91%

Fundamentals CPRX

review the fundamentals of Catalyst Pharmaceuticals shares

P/E

17.88

Sector: -4.17 Industry: -4.17

P/S (PSR)

6.51

Sector: -3.93 Industry: -3.93

P/BV

4.02

Sector: 1.97 Industry: 1.97

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

19.41%

Sector: -61.85% Industry: -61.85%

ROE

22.46%

Sector: -61.77% Industry: -61.77%

ROIC

71.79%

Sector: -2,169.53% Industry: -2,169.53%

NET MARGIN

36.39%

Sector: -39.93% Industry: -39.93%

GROSS MARGIN

85.19%

Sector: 36.95% Industry: 36.95%

OPERATING MARGIN

43.77%

Sector: -39.40% Industry: -39.40%

EV/EBITDA

12.96

Sector: -4.22 Industry: -4.22

EV/EBIT

14.86

Sector: -4.27 Industry: -4.27

PRICE-TO-ASSETS

3.47

Sector: 1.42 Industry: 1.42

BVPS

7.76

Sector: 1.88 Industry: 1.88

EPS

1.74

Sector: -2.09 Industry: -2.09

EQUITY-TO-ASSETS RATIO

0.86

Sector: 0.43 Industry: 0.43

LIABILITIES / ASSETS

0.14

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

53.77%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

40.26%

Sector: - Industry: -

FAIR VALUE OF Catalyst Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 31.18

Fair Value

$ 0.00

Upside/Downside Return potential.

-44.10%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CPRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	25.34	6.57	25.92%	2.35%	$ 533.16 B	21.83%
PFE	19.20	1.59	8.29%	6.81%	$ 143.77 B	11.83%
ABBV	98.09	0.00	0.00%	3.30%	$ 356.54 B	5.79%
NVO	10.79	6.52	60.40%	4.05%	$ 204.69 B	37.15%
MRK	30.79	0.00	0.00%	2.98%	$ 275.11 B	13.59%
AZN	27.26	5.98	21.93%	1.75%	$ 283.23 B	17.19%
GILD	17.70	6.96	39.33%	2.43%	$ 163.11 B	30.99%
BMY	15.73	0.00	0.00%	4.45%	$ 114.45 B	15.01%
ZTS	13.23	10.81	81.75%	2.45%	$ 34.95 B	27.79%
REGN	16.81	2.37	14.08%	0.50%	$ 74.35 B	29.65%
HALO	23.88	155.01	649.21%	0.00%	$ 7.57 B	22.69%
AMGN	22.96	19.49	84.87%	2.91%	$ 179.12 B	20.96%
MCK	18.86	-107.68	-570.98%	0.43%	$ 89.80 B	1.18%
HRMY	12.34	1.97	16.00%	0.00%	$ 1.80 B	16.20%
VRTX	25.17	5.64	22.41%	0.00%	$ 109.17 B	35.51%
CAH	27.75	-16.15	-58.20%	1.11%	$ 43.16 B	0.62%
ADMA	11.66	4.94	42.37%	0.00%	$ 1.93 B	32.43%
BIIB	20.73	1.52	7.36%	0.00%	$ 28.44 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

CPRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (3 people)

United States

20 years

Founded: 2006

2006

Time since IPO - 20 years

74

Employees

Catalyst Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.83 Billions, with shareholders equity totaling $954.27 Millions.

The company employs approximately 74 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Catalyst Pharmaceuticals Inc. reported $588.98 Millions in revenue, generating net income of $214.33 Millions.

Key financial metrics include a P/E ratio of 17.88, a price-to-book (P/B) ratio of 4.02, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CPRX.

Market cap

$ 3.83 Billions

Net worth

$ 954.27 Millions

$ 954,270,000.00

Assets

$ 1.10 Billion

$ 1,103,980,000.00

Total Shares Outstanding

123.00 Millions

123,000,000

Average Daily Trading Volume

$ 1.86 Million

$ 1,856,577.56

Sector

Health Care

Industry

Biotechnology

CPRX

CPRX revenue and profits

Financial Results CPRX

DRAG THE FRAME TO SEE MORE DATA

CPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 760.57 5,56% (12M)

P/E

18.86

0.43%

ROE

-570.98%

P/BV

-107.68

CAH - Cardinal Health

$ 195.20 28,34% (12M)

P/E

27.75

1.11%

ROE

-58.20%

P/BV

-16.15

JNJ - Johnson & Johnson

$ 226.71 54,92% (12M)

P/E

25.34

2.35%

ROE

25.92%

P/BV

6.57

MRK - Merck & Co.

$ 111.38 51,76% (12M)

P/E

30.79

2.98%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 181.58 32,61% (12M)

P/E

27.26

1.75%

ROE

21.93%

P/BV

5.98

ABBV - AbbVie

$ 210.39 17,96% (12M)

P/E

98.09

3.30%

ROE

0.00%

P/BV

0.00

NVO - Novo Nordisk

$ 44.74 --27,13% (12M)

P/E

10.79

4.05%

ROE

60.40%

P/BV

6.52

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 760.57 5,56% (12 M)

P/L

18.86

0.43%

ROE

-570.98%

P/VP

-107.68

CAH - Cardinal Health

$ 195.20 28,34% (12 M)

P/L

27.75

1.11%

ROE

-58.20%

P/VP

-16.15

JNJ - Johnson & Johnson

$ 226.71 54,92% (12 M)

P/L

25.34

2.35%

ROE

25.92%

P/VP

6.57

MRK - Merck & Co.

$ 111.38 51,76% (12 M)

P/L

30.79

2.98%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 181.58 32,61% (12 M)

P/L

27.26

1.75%

ROE

21.93%

P/VP

5.98

ABBV - AbbVie

$ 210.39 17,96% (12 M)

P/L

98.09

3.30%

ROE

0.00%

P/VP

0.00

NVO - Novo Nordisk

$ 44.74 --27,13% (12 M)

P/L

10.79

4.05%

ROE

60.40%

P/VP

6.52

Frequently Asked Questions

What is the price of Catalyst Pharmaceuticals (CPRX) today?

A cotação de Catalyst Pharmaceuticals (CPRX) hoje está em $ 31.18, com uma variação de The stock began the year trading around $ 23.34 and is currently priced at $ 31.18. negociando na casa dos $ 23.34 e hoje está em $ 31.18. Acompanhe o and track broader market trends directly on the platform.

When does Catalyst Pharmaceuticals (CPRX) pay dividends?

Catalyst Pharmaceuticals (CPRX) did not pay dividends over the past year.

Is Catalyst Pharmaceuticals (CPRX) a good investment?

Atualmente, Catalyst Pharmaceuticals (CPRX) está cotada a $ 31.18, com um P/L de 17.88, This represents a 2,086% premium compared to its historical average P/E. uma variação de 31.12 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 31.12%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Catalyst Pharmaceuticals (CPRX) stock?

You can buy Catalyst Pharmaceuticals (CPRX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CPRX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Catalyst Pharmaceuticals (CPRX) yield today?

Over the past month, Catalyst Pharmaceuticals (CPRX) has returned 20.62% — 31.12% over the past year, and 467.94% over the past five years, including price appreciation and dividends.

Nos últimos 12 meses, a empresa pagou um total de $ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Catalyst Pharmaceuticals (CPRX) hoje, o investimento total seria de $ 3,118.00, com base na cotação atual de $ 31.18.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: $ 4,088.32
Em 5 anos: $ 17,708.37
Em 10 anos: $ 166,186.59

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CPRX

Catalyst Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CPRX

review the fundamentals of Catalyst Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc.

United States

20 years

2006

74

PROFIT X PRICE CPRX

Financial Results CPRX

CPRX cash flow

Asset, Revenue and Profit Growth - CPRX

CPRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions